scholarly article | Q13442814 |
P2093 | author name string | Feng Chen | |
Jing Wang | |||
Xin Li | |||
Songdong Meng | |||
Weiwei Liu | |||
Xiaoyu Chu | |||
Junwei Hou | |||
Mengmeng Deng | |||
P2860 | cites work | A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells | Q24302285 |
OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD | Q24312778 | ||
ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways | Q33528959 | ||
Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol | Q33564705 | ||
Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells | Q33576337 | ||
Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling | Q33780210 | ||
Synuclein gamma stimulates membrane-initiated estrogen signaling by chaperoning estrogen receptor (ER)-alpha36, a variant of ER-alpha. | Q34033382 | ||
A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling | Q34694795 | ||
Human estrogen receptor-alpha: regulation by synthesis, modification and degradation. | Q34712217 | ||
Heat shock protein 70 and glycoprotein 96 are differentially expressed on the surface of malignant and nonmalignant breast cells | Q35239546 | ||
A positive cross-regulation of HER2 and ER-α36 controls ALDH1 positive breast cancer cells | Q35563328 | ||
Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36) | Q35802058 | ||
ER-α36, a novel isoform of ER-α66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast. | Q36048992 | ||
A variant of estrogen receptor-alpha, ER-alpha36 is expressed in human gastric cancer and is highly correlated with lymph node metastasis | Q36049050 | ||
Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion | Q36607449 | ||
Placenta-derived gp96 as a multivalent prophylactic cancer vaccine | Q36907244 | ||
Proteasome-dependent degradation of the human estrogen receptor | Q37160826 | ||
Tamoxifen resistance in breast cancer | Q37224555 | ||
Identification of the cellular sentinels for native immunogenic heat shock proteins in vivo. | Q37240798 | ||
Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer | Q37280705 | ||
A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells | Q37387466 | ||
Plasma membrane gp96 enhances invasion and metastatic potential of liver cancer via regulation of uPAR | Q38891038 | ||
Cell membrane gp96 facilitates HER2 dimerization and serves as a novel target in breast cancer | Q38924681 | ||
Involvement of ER-α36 in the malignant growth of gastric carcinoma cells is associated with GRP94 overexpression | Q39129957 | ||
Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. | Q40373157 | ||
Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells | Q41134570 | ||
ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas | Q41889851 | ||
"Dwarf" estrogen receptor in breast cancer and resistance to tamoxifen. | Q45987225 | ||
Cell surface expression of the endoplasmic reticular heat shock protein gp96 is phylogenetically conserved | Q56902083 | ||
Tumor-specific cell surface expression of the -KDEL containing endoplasmic reticular heat shock protein gp96 | Q60021885 | ||
The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators | Q74265958 | ||
Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues | Q81783904 | ||
Evidence for U.S. Preventive Services Task Force (USPSTF) recommendations against routine mammography for females between 40-49 years of age | Q95545050 | ||
P433 | issue | 31 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | molecular chaperones | Q422496 |
P304 | page(s) | 31857-31867 | |
P577 | publication date | 2015-09-10 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Chaperone gp96 mediates ER-α36 cell membrane expression | |
P478 | volume | 6 |
Q87611783 | Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior |
Q55256765 | Estrogen receptor-α36-mediated rapid estrogen signaling regulates 78 kDa glucose-regulated protein expression in gastric carcinoma cells. |
Q59797790 | Externalized Keratin 8: A Target at the Interface of Microenvironment and Intracellular Signaling in Colorectal Cancer Cells |
Search more.